Developed in conjunction with

April, 2014
SOM Biotech and The Vall d'Hebron Institute of...
March, 2014
SOM Biotech attended Bio-Europe Spring 2014 in Turin. 2,000 high-level executives from pharma, biotech, venture capital...

September, 2012

A recent Thomson Reuters report indicates that drug repositioning is expected to generate up to $20Billion in annual sales during 2012, thus opening up a new source of revenue to large, medium and small Pharma companies.